biote Corp - Class A
Research biote Corp - Class A (BTMD) on Bullrun: market cap USD 43.71M, P/E 13.1. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBTMD
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Care Facilities
- CurrencyUSD
- Market capUSD 43.71M
- P/E13.1
- Financial periodQ1 2026
- RevenueUSD 44.94M
- Net incomeUSD 2.28M
- Free cash flowUSD 26.45M
- Gross margin68.9%
Valuation Snapshot
latest market cap is USD 43.71M; P/E is 13.1.
Peer valuation comparison
Latest P/E is 13.12x versus a Healthcare sector median of 24.46x (46.3% below).
Latest P/E is 13.12x versus a United States median of 24.87x (47.2% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 192.22M | USD 27.05M | USD 30.18M | 71.5% | 0.74 | USD 24.12M | USD 102.03M | -USD 58.54M |
| FY2024 | USD 197.19M | USD 3.16M | USD 38.81M | 70.4% | 0.09 | USD 39.34M | USD 107.45M | -USD 105.93M |
| FY2023 | USD 185.36M | USD 3.32M | USD 26.52M | n/a | 0.13 | USD 89.00M | USD 112.88M | -USD 29.40M |
| FY2022 | USD 164.96M | -USD 969.00K | -USD 9.49M | n/a | -0.12 | USD 79.23M | USD 118.34M | -USD 44.46M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 43.71M | 13.1 | n/a | n/a |
| 2025 | 2025-12-31 | USD 79.85M | 3.4 | n/a | n/a |
| 2024 | 2024-12-31 | USD 194.58M | 61.8 | n/a | n/a |
| 2023 | 2023-12-29 | USD 167.67M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 34.59M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | n/a | 5.0 | n/a | n/a |
About biote Corp - Class A
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is biote Corp - Class A's market cap?
biote Corp - Class A's market capitalization is USD 43.71M.
What is biote Corp - Class A's P/E ratio?
biote Corp - Class A's price-to-earnings (P/E) ratio is 13.1.
What does biote Corp - Class A do?
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance.